Alter the Cost of Access Trends on Your Brand Revenue
Pharmaceutical SVP/VP Market Access, VP Key Accounts, SVP Therapeutic Business Units, Brand Directors, VPs Contracting, VPs Finance:
Are you exhausted by the intensifying payer impact on the cost of brand access and its negative effect on gross-to-net brand revenue?
Stricter prior authorizations, formulary exclusions, member cost shifting, Rx deductibles, and co-pay maximizers can negatively impact year-end budget forecasts. These aggressive techniques are significantly impacting patient out-of-pocket costs, which can lead to patients avoiding drug therapy or abandoning prescriptions at the pharmacy. All brands suffer from unfulfilled prescriptions with Rx rejections and abandonment rates varying by brand. The impact is significantly growing and negatively affecting brand sales forecasts and revenue.
The result is frustration across stakeholders:
Patients—despair, dissatisfaction, and poor treatment outcomes
Providers—disruption of patient care plans and prescribing hesitancy
Manufacturers—unrealized patient access to drug innovation and reduced brand sales
So, how can you lower the rate of Rx rejections and abandonment at the dispensing point of service?
Introducing RxRecovery™—an artificial intelligence (AI) technology platform that increases Rx fulfillment by identifying appropriate patients who may qualify for alternative coverage options. RxRecovery is an AI and automated real-time Rx recovery solution that provides federal anti-kickback compliant support to:
Address Rx abandonment and claims rejection with real-time patient benefit profiles
Secure alternative coverage options for eligible patients by targeting select Rx rejection codes
Help patients acquire their initial prescription at the Rx dispensing point of service
Integrate with switch, pharmacy benefit manager, or existing pharmacy system for automated real-time recovery
Minimize human time/cost with interoperability
Realize Improved Rx Fulfillment With RxRecovery—It’s NOT Magic
RxRecovery is proven to help overcome Rx rejections and abandonment by converting unfulfilled to dispensed Rxs. Successful implementation can help increase Rx fulfillment, keep patients on therapy, and drive brand sales and revenue. The RxRecovery platform provides you with a vehicle to alter the impact of payer access challenges and positively contribute to brand sales and revenue.
To learn more about RxRecovery and how we can help you drive brand revenue by increasing Rx fulfillment, please reach out to:
Dave Dierk, Co-President, 30-year sales and marketing thought leader in pharmaceutical diagnostics, biomedical, long-term care, managed care, employer, and pharmacy communications, at firstname.lastname@example.org.
Paul G. Pochtar, RPh, extensive experience in leading the successful market access commercialization of both primary care and specialty pharmaceuticals throughout their life cycle, including several landmark oncology products and other specialty therapeutics, at email@example.com.
Making a difference in patient care by helping patients, providers, and payers collaborate on shared priorities